Clinical Trials
7 trialsNCT03819296 2026-03-11
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04407247 2025-12-23
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT03011268 2025-05-31
BIOSTOP
Helse Møre og Romsdal HF
Phase NA Completed
NCT04646187 2025-01-06
FREE
University Medical Center Groningen
Phase 4 Enrolling by invitation
NCT03452501 2021-02-23
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients
Hikma Pharmaceuticals LLC
Completed
NCT03348046 2020-03-04
PASSRRA
Hikma Pharmaceuticals LLC
Completed
NCT02457585 2017-05-15
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
Seoul National University Hospital
Phase 2 Unknown